Developing Medical Devices to Treat Pain

Funding Opportunity Announcements (FOAs)

This program is part of the NIH HEAL Initiative.

Notices of additional receipt date for FOAs listed below:

Notice of Change to Key Dates for RFA-EB-18-003 HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
 
Notice of Change to Key Dates for RFA-NS-19-016 HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
 
Notice of Change to Key Dates for RFA-NS-19-017 HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)
 
Notice of Change to Key Dates for RFA-NS-19-018 HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
 

FOAs

HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
RFA-EB-18-003

HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
RFA-NS-19-016

HEAL Initiative Translational Devices to Treat Pain (U44 Clinical Trial Optional)
RFA-NS-19-017

HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
RFA-NS-19-018

HEAL Initiative: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Anatomical and Functional Mapping of Pain-Related Visceral Organ Neural Circuitry (U01 Clinical Trial Optional)
RFA-RM-19-001

Webinar 

Three webinars were held in December 2018 that introduced the audience to the funding opportunity announcements (FOAs), all seeking to develop medical devices to treat pain.  These FOAs support different degrees of technological maturity.  All focus on approaches that target the nervous system to provide therapeutic, rehabilitative, or diagnostic capability.  

Click here to download webinar slides


Frequently Asked Questions